These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 16537421)
1. Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. Wang G; Barrett JW; Stanford M; Werden SJ; Johnston JB; Gao X; Sun M; Cheng JQ; McFadden G Proc Natl Acad Sci U S A; 2006 Mar; 103(12):4640-5. PubMed ID: 16537421 [TBL] [Abstract][Full Text] [Related]
2. M-T5, the ankyrin repeat, host range protein of myxoma virus, activates Akt and can be functionally replaced by cellular PIKE-A. Werden SJ; Barrett JW; Wang G; Stanford MM; McFadden G J Virol; 2007 Mar; 81(5):2340-8. PubMed ID: 17151107 [TBL] [Abstract][Full Text] [Related]
3. Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells. Stanford MM; Barrett JW; Nazarian SH; Werden S; McFadden G J Virol; 2007 Feb; 81(3):1251-60. PubMed ID: 17108021 [TBL] [Abstract][Full Text] [Related]
4. The role of cell signaling in poxvirus tropism: the case of the M-T5 host range protein of myxoma virus. Werden SJ; McFadden G Biochim Biophys Acta; 2008 Jan; 1784(1):228-37. PubMed ID: 17905673 [TBL] [Abstract][Full Text] [Related]
5. Oncolysis of canine tumor cells by myxoma virus lacking the serp2 gene. Urbasic AS; Hynes S; Somrak A; Contakos S; Rahman MM; Liu J; MacNeill AL Am J Vet Res; 2012 Aug; 73(8):1252-61. PubMed ID: 22849686 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological manipulation of the akt signaling pathway regulates myxoma virus replication and tropism in human cancer cells. Werden SJ; McFadden G J Virol; 2010 Apr; 84(7):3287-302. PubMed ID: 20106927 [TBL] [Abstract][Full Text] [Related]
7. The myxoma virus m-t5 ankyrin repeat host range protein is a novel adaptor that coordinately links the cellular signaling pathways mediated by Akt and Skp1 in virus-infected cells. Werden SJ; Lanchbury J; Shattuck D; Neff C; Dufford M; McFadden G J Virol; 2009 Dec; 83(23):12068-83. PubMed ID: 19776120 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518 [TBL] [Abstract][Full Text] [Related]
9. Myxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell cullin-1. Johnston JB; Wang G; Barrett JW; Nazarian SH; Colwill K; Moran M; McFadden G J Virol; 2005 Aug; 79(16):10750-63. PubMed ID: 16051867 [TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus Us3(-) mutant as oncolytic strategy and synergizes with phosphatidylinositol 3-kinase-Akt targeting molecular therapeutics. Liu TC; Wakimoto H; Martuza RL; Rabkin SD Clin Cancer Res; 2007 Oct; 13(19):5897-902. PubMed ID: 17908985 [TBL] [Abstract][Full Text] [Related]
11. [Study in the killing effect of Myxoma virus to C6 glioma cell in vitro]. Zang M; Zhang QS; Liang SJ; Ji T; Lin HZ; Li WP Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Feb; 26(1):43-5. PubMed ID: 22919752 [TBL] [Abstract][Full Text] [Related]
12. Roles of MKK1/2-ERK1/2 and phosphoinositide 3-kinase-AKT signaling pathways in erlotinib-induced Rad51 suppression and cytotoxicity in human non-small cell lung cancer cells. Ko JC; Ciou SC; Jhan JY; Cheng CM; Su YJ; Chuang SM; Lin ST; Chang CC; Lin YW Mol Cancer Res; 2009 Aug; 7(8):1378-89. PubMed ID: 19671683 [TBL] [Abstract][Full Text] [Related]
13. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells. Asselin E; Mills GB; Tsang BK Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739 [TBL] [Abstract][Full Text] [Related]
14. Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity. Correa RJ; Komar M; Tong JG; Sivapragasam M; Rahman MM; McFadden G; Dimattia GE; Shepherd TG Gynecol Oncol; 2012 May; 125(2):441-50. PubMed ID: 22306204 [TBL] [Abstract][Full Text] [Related]
15. Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells. Tomita M; Semenza GL; Michiels C; Matsuda T; Uchihara JN; Okudaira T; Tanaka Y; Taira N; Ohshiro K; Mori N Biochem J; 2007 Sep; 406(2):317-23. PubMed ID: 17576198 [TBL] [Abstract][Full Text] [Related]
16. Recombinant myxoma virus lacking all poxvirus ankyrin-repeat proteins stimulates multiple cellular anti-viral pathways and exhibits a severe decrease in virulence. Lamb SA; Rahman MM; McFadden G Virology; 2014 Sep; 464-465():134-145. PubMed ID: 25068401 [TBL] [Abstract][Full Text] [Related]
17. Reovirus infection induces apoptosis of TRAIL-resistant gastric cancer cells by down-regulation of Akt activation. Cho IR; Koh SS; Min HJ; Park EH; Srisuttee R; Jhun BH; Kang CD; Kim M; Johnston RN; Chung YH Int J Oncol; 2010 Apr; 36(4):1023-30. PubMed ID: 20198349 [TBL] [Abstract][Full Text] [Related]
18. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus. Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533 [TBL] [Abstract][Full Text] [Related]
19. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. St-Germain ME; Gagnon V; Parent S; Asselin E Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316 [TBL] [Abstract][Full Text] [Related]
20. Activation of mammalian target of rapamycin in transformed B lymphocytes is nutrient dependent but independent of Akt, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase, insulin growth factor-I, and serum. Wlodarski P; Kasprzycka M; Liu X; Marzec M; Robertson ES; Slupianek A; Wasik MA Cancer Res; 2005 Sep; 65(17):7800-8. PubMed ID: 16140948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]